有风险的业务:在高风险患者中进行阴茎假体
Sukhjeevan S Nijhar1, Charlotte C Goldman2, Joanna Orzel1
1School of Medicine, Georgetown University, Washington, DC, USA.
Translational andrology and urology
|October 24, 2025
概括
接受阴茎假肢手术的糖尿病患者没有经历更高的并发症率. 术前高血糖和高HbA1c水平与设备感染,侵蚀或故障的风险增加无关.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗器械技术 医疗器械技术
- 内分泌学 在内分泌学.
背景情况:
- 患有糖尿病和免疫功能受损的患者可能面临更高的阴茎假肢风险.
- 对于这种高风险人群,数据有限且矛盾.
- 这项研究回顾了三级医疗中心高风险患者的结果.
研究的目的:
- 调查术前高血糖和阴茎假肢并发症之间的关联.
- 为了确定高血糖化血红蛋白 (HbA1c) 水平是否会增加设备感染,侵蚀或故障的风险.
主要方法:
- 对235个阴茎假肢插入 (2012-2023) 的回顾性审查.
- 收集的手术前期HbA1c,平均和最大血糖水平.
- 主要结局:设备感染需要重新操作;次要结局:侵蚀,故障.
主要成果:
- 在糖尿病患者 (2.8%) 和非糖尿病患者 (3.4%) 之间,对于设备感染的重新手术率没有显著差异.
- 在糖尿病患者中,外科期间的HbA1c和血糖水平较高.
- 在HbA1c切线值为8.5或10g/dL时,没有观察到假肢并发症率的增加.
结论:
- 糖尿病患者在阴茎假肢手术后没有经历较高的设备相关并发症率.
- 在手术前的HbA1c水平 (8.5或10g/dL) 和增加的假肢并发症之间没有发现联系.
- 在这个队列中,外科手术期间的高血糖症似乎不会增加阴茎假肢并发症的风险.
更多相关视频
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
728
03:25Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
Published on: June 16, 2022
1.3K
相关概念视频
01:20Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457